Anti-inflammatory properties of anthraquinones and their relationship with the regulation of P-glycoprotein function and expression

European Journal of Pharmaceutical Sciences

Volumn 48, Issue 1-2, 2013, Pages 272-281

  Choi, Ran Joo ^a   Ngoc, Tran Minh ^b   Bae, Kihwan ^b   Cho, Hyun Jong ^a,c   Kim, Dae Duk ^a   Chun, Jaemoo ^a   Khan, Salman ^a   Kim, Yeong Shik ^a  

^a Seoul National University   (South Korea)

^b Chungnam National University   (South Korea)

^c Kangwon National University   (South Korea)

Author keywords

Anthraquinones; Anti inflammatory; COX 2; P glycoprotein; Rhubarb

Indexed keywords

ALOE EMODIN; CARRAGEENAN; CHRYSOPHANIC ACID; CYCLOOXYGENASE 2; DNA; EMODIN; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MULTIDRUG RESISTANCE PROTEIN; PHYSCION; PROSTAGLANDIN E2; RHEIN; RHODAMINE 123; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG TRANSPORT; GEL MOBILITY SHIFT ASSAY; MACROPHAGE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; RHUBARB;

ANIMALS; ANTHRAQUINONES; ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; CARRAGEENAN; CELL LINE; CELL SURVIVAL; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; EDEMA; HUMANS; MALE; MICE; MICE, INBRED ICR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; P-GLYCOPROTEIN; PHYTOTHERAPY; PLANT EXTRACTS; RHEUM; RHIZOME; RNA, MESSENGER;

EID: 84870723319     PISSN: 09280987     EISSN: 18790720     Source Type: Journal    
DOI: 10.1016/j.ejps.2012.10.027     Document Type: Article

References (49)

1. S.V. Ambudkar, S. Dey, C.A. Hrycyna, M. Ramachandra, I. Pastan, and M.M. Gottesman Biochemical, cellular, and pharmacological aspects of the multidrug transporter Annu. Rev. Pharmacol. Toxicol. 39 1999 361 398
2. P. Artursson Epithelial transport of drugs in cell culture. I: a model for studying the passive diffusion of drugs over intestinal absorptive (Caco-2) cells J. Pharm. Sci. 79 1990 476 482
3. R.J. Choi, E.M. Shin, H.A. Jung, J.S. Choi, and Y.S. Kim Inhibitory effects of kaurenoic acid from Aralia continentalis on LPS-induced inflammatory response in RAW264.7 macrophages Phytomedicine 18 2011 677 682
4. C. Cordon-Cardo, J.P. O'Brien, D. Casals, L. Rittman-Grauer, J.L. Biedler, M.R. Melamed, and J.R. Bertino Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proc. Natl. Acad. Sci. USA 86 1989 695 698
5. M.J. Cuellar, R.M. Giner, M.C. Recio, S. Manez, and J.L. Rios Topical anti-inflammatory activity of some Asian medicinal plants used in dermatological disorders Fitoterapia 72 2001 221 229
6. A.H. Dantzig, K.L. Law, J. Cao, and J.J. Starling Reversal of multidrug resistance by the P-glycoprotein modulator, LY335979, from the bench to the clinic Curr. Med. Chem. 8 2001 39 50
7. L.C. Denlinger, P.L. Fisette, K.A. Garis, G. Kwon, A. Vazquez-Torres, A.D. Simon, B. Nguyen, R.A. Proctor, P.J. Bertics, and J.A. Corbett Regulation of inducible nitric oxide synthase expression by macrophage purinoreceptors and calcium J. Biol. Chem. 271 1996 337 342
8. C.A. Dinarello Anti-inflammatory agents: present and future Cell 140 2010 935 950
9. M. Fan, and T.C. Chambers Role of mitogen-activated protein kinases in the response of tumor cells to chemotherapy Drug. Resist. Update 4 2001 253 267
10. D.R. Ferry Testing the role of P-glycoprotein expression in clinical trials: applying pharmacological principles and best methods for detection together with good clinical trials methodology Int. J. Clin. Pharmacol. Ther. 36 1998 29 40
11. J.M. Ford Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisers Eur. J. Cancer 32A 1996 991 1001
12. A. Fugh-Berman, and E. Ernst Herb-drug interactions: review and assessment of report reliability Br. J. Clin. Pharmacol. 52 2001 587 595
13. P. Gros, J. Croop, and D. Housman Mammalian multidrug resistance gene: complete cDNA sequence indicates strong homology to bacterial transport proteins Cell 47 1986 371 380
14. X. Guo, N. Ma, J. Wang, J. Song, X. Bu, Y. Cheng, K. Sun, H. Xiong, G. Jiang, B. Zhang, M. Wu, and L. Wei Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells BMC Cancer 8 2008 375
15. M. Han, and X.L. Fang Difference in oral absorption of ginsenoside Rg1 between in vitro and in vivo models Acta Pharmacol. Sin. 27 2006 499 505
16. Z. Hu, X. Yang, P.C. Ho, S.Y. Chan, P.W. Heng, E. Chan, W. Duan, H.L. Koh, and S. Zhou Herb-drug interactions: a literature review Drugs 65 2005 1239 1282
17. J. Iqbal, F. Sarti, G. Perera, and A. Bernkop-Schnurch Development and in vivo evaluation of an oral drug delivery system for paclitaxel Biomaterials 32 2011 170 175
18. S.S. Jakobsen, A. Larsen, M. Stoltenberg, J.M. Bruun, and K. Soballe Effects of as-cast and wrought Cobalt-Chrome-Molybdenum and Titanium-Aluminium- Vanadium alloys on cytokine gene expression and protein secretion in J774A.1 macrophages Eur. Cells Mater. 14 2007 45 54 discussion 54-45
19. J.H. Jin, T.M. Ngoc, K. Bae, Y.S. Kim, and H.P. Kim Inhibition of experimental atopic dermatitis by rhubarb (rhizomes of Rheum tanguticum) and 5-lipoxygenase inhibition of its major constituent, emodin Phytother. Res. 25 2011 755 759
20. R.L. Juliano, and V. Ling A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants Biochim. Biophys. Acta 455 1976 152 162
21. R.B. Kim Drugs as P-glycoprotein substrates, inhibitors, and inducers Drug. Metab. Rev. 34 2002 47 54
22. S. Labialle, L. Gayet, E. Marthinet, D. Rigal, and L.G. Baggetto Transcriptional regulators of the human multidrug resistance 1 gene: recent views Biochem. Pharmacol. 64 2002 943 948
23. D.A. Laska, J.O. Houchins, S.E. Pratt, J. Horn, X. Xia, B.R. Hanssen, D.C. Williams, A.H. Dantzig, and T. Lindstrom Characterization and application of a vinblastine-selected Caco-2 cell line for evaluation of p-glycoprotein In Vitro Cell Dev. Biol. Anim. 38 2002 401 410
24. V. Ling, and L.H. Thompson Reduced permeability in CHO cells as a mechanism of resistance to colchicine J. Cell Physiol. 83 1974 103 116
25. K.J. Moore, and I. Tabas Macrophages in the pathogenesis of atherosclerosis Cell 145 2011 341 355
26. T.M. Ngoc, P.T. Minh, T.M. Hung, P.T. Thuong, I. Lee, B.S. Min, and K. Bae Lipoxygenase inhibitory constituents from rhubarb Arch. Pharm. Res. 31 2008 598 605
27. R.P. Nishanth, B.S. Ramakrishna, R.G. Jyotsna, K.R. Roy, G.V. Reddy, P.K. Reddy, and P. Reddanna C-Phycocyanin inhibits MDR1 through reactive oxygen species and cyclooxygenase-2 mediated pathways in human hepatocellular carcinoma cell line Eur. J. Pharmacol. 649 2010 74 83
28. M.H. Pan, C.S. Lai, Y.J. Wang, and C.T. Ho Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice Biochem. Pharmacol. 72 2006 1293 1303
29. M.Y. Park, H.J. Kwon, and M.K. Sung Intestinal absorption of aloin, aloe-emodin, and aloesin; a comparative study using two in vitro absorption models Nutr Res Pract 3 2009 9 14
30. V.A. Patel, M.J. Dunn, and A. Sorokin Regulation of MDR-1 (P-glycoprotein) by cyclooxygenase-2 J. Biol. Chem. 277 2002 38915 38920
31. Y. Qu, J.B. Wang, H.F. Li, Q. Wnag, X.H. Xiao, and Y.Z. He Study on relationship of laxative potency and anthraquinones content traditional Chinese drugs Zhongguo Zhong Yao Za Zhi 33 2008 806 808
32. M.J. Robinson, and M.H. Cobb Mitogen-activated protein kinase pathways Curr. Opin. Cell Biol. 9 1997 180 186
33. E. Roger, F. Lagarce, E. Garcion, and J.P. Benoit Reciprocal competition between lipid nanocapsules and P-gp for paclitaxel transport across Caco-2 cells Eur. J. Pharm. Sci. 40 2010 422 429
34. K.R. Roy, G.V. Reddy, L. Maitreyi, S. Agarwal, C. Achari, S. Vali, and P. Reddanna Celecoxib inhibits MDR1 expression through COX-2-dependent mechanism in human hepatocellular carcinoma (HepG2) cell line Cancer Chemother. Pharmacol. 65 2010 903 911
35. E.M. Shin, S. Kim, I. Merfort, and Y.S. Kim Glycyrol induces apoptosis in human Jurkat T cell lymphocytes via the Fas-FasL/caspase-8 pathway Planta. Med. 77 2011 242 247
36. G. Srinivas, S. Babykutty, P.P. Sathiadevan, and P. Srinivas Molecular mechanism of emodin action: transition from laxative ingredient to an antitumor agent Med. Res. Rev. 27 2007 591 608
37. H. Sui, S. Zhou, Y. Wang, X. Liu, L. Zhou, P. Yin, Z. Fan, and Q. Li COX-2 contributes to P-glycoprotein-mediated multidrug resistance via phosphorylation of c-Jun at Ser63/73 in colorectal cancer Carcinogenesis 32 2011 667 675
38. C. Tabolacci, A. Lentini, P. Mattioli, B. Provenzano, S. Oliverio, F. Carlomosti, and S. Beninati Antitumor properties of aloe-emodin and induction of transglutaminase 2 activity in B16-F10 melanoma cells Life Sci. 87 2010 316 324
39. K. Takara, S. Horibe, Y. Obata, E. Yoshikawa, N. Ohnishi, and T. Yokoyama Effects of 19 herbal extracts on the sensitivity to paclitaxel or 5-fluorouracil in HeLa cells Biol. Pharm. Bull. 28 2005 138 142
40. F. Thiebaut, T. Tsuruo, H. Hamada, M.M. Gottesman, I. Pastan, and M.C. Willingham Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues Proc. Natl. Acad. Sci. USA 84 1987 7735 7738
41. B. Waltenberger, B. Avula, M. Ganzera, I.A. Khan, H. Stuppner, and S.I. Khan Transport of sennosides and sennidines from Cassia angustifolia and Cassia senna across Caco-2 monolayers-an in vitro model for intestinal absorption Phytomedicine 15 2008 373 377
42. W.I. Wei, H. Chen, Z.L. Ni, H.I. Liu, H.F. Tong, L. Fan, A. Liu, M.U. Qiu, D.L. Liu, H.C. Guo, Z.H. Wang, and S.Z. Lin Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill against pancreatic cancer in mice via inhibition of Akt activation Int. J. Oncol. 39 2011 1381 1390
43. D.Y. Yang, H. Fushimi, S.Q. Cai, and K. Komatsu Molecular analysis of Rheum species used as Rhei Rhizoma based on the chloroplast matK gene sequence and its application for identification Biol. Pharm. Bull. 27 2004 375 383
44. H. Yang, L.N. Xu, C.Y. He, X. Liu, R.Y. Fang, and T.H. Ma CFTR chloride channel as a molecular target of anthraquinone compounds in herbal laxatives Acta Pharmacol. Sin. 32 2011 834 839
45. S. Yee In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man-fact or myth Pharm. Res. 14 1997 763 766
46. H.H. Yoo, M. Lee, M.W. Lee, S.Y. Lim, J. Shin, and D.H. Kim Effects of Schisandra lignans on P-glycoprotein-mediated drug efflux in human intestinal Caco-2 Planta. Med. 73 2007 444 450
47. U. Zabel, R. Schreck, and P.A. Baeuerle DNA binding of purified transcription factor NF-kappa B. Affinity, specificity, Zn2+ dependence, and differential half-site recognition J. Biol. Chem. 266 1991 252 260
48. A. Zrieki, R. Farinotti, and M. Buyse Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line Pharm. Res. 25 2008 1991 2001
49. A. Zrieki, R. Farinotti, and M. Buyse Cyclooxygenase-2 inhibitors prevent trinitrobenzene sulfonic acid-induced P-glycoprotein up-regulation in vitro and in vivo Eur. J. Pharmacol. 636 2010 189 197